NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

Good article, but not DCVax. First clue was:

The trial was led by Dr Paul Mulholland, a brain cancer specialist at University College Hospital in London, who said it proves a cure may finally be possible for glioblastoma patients.

So not Dr. Ashkan at King’s College Hospital.

Next clue:

Mulholland’s world-first trial giving the immunotherapy drug ipilimumab before other treatments had to close with Trotman its only patient, because of a lack of referrals from NHS clinics. However, he said it was “all worth it, to see a couple get married and have a happy life”, and now hopes to offer the treatment to more newly diagnosed NHS patients in future trials.

So ipilimumab, not DCVax.
But yes, keep the articles coming to raise awareness about Glioblastoma.